146 related articles for article (PubMed ID: 24803482)
21. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
22. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
23. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
24. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
25. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
26. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
27. Breast screening: axillary lymph node status of interval cancers by interval year.
Bucchi L; Puliti D; Ravaioli A; Cortesi L; De Lisi V; Falcini F; Ferretti S; Frigerio A; Mangone L; Petrella M; Petrucci C; Sassoli de Bianchi P; Traina A; Tumino R; Zanetti R; Zorzi M; Paci E
Breast; 2008 Oct; 17(5):477-83. PubMed ID: 18455401
[TBL] [Abstract][Full Text] [Related]
28. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
29. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
[TBL] [Abstract][Full Text] [Related]
30. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
[TBL] [Abstract][Full Text] [Related]
31. Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
Iwamoto T; Kumamaru H; Miyata H; Tomotaki A; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Matsuoka J; Doihara H; Kinoshita T; Nakamura S; Tokuda Y
Breast Cancer Res Treat; 2016 Apr; 156(3):485-494. PubMed ID: 27048417
[TBL] [Abstract][Full Text] [Related]
32. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
33. Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.
Yuan Y; Li M; Yang J; Elliot T; Dabbs K; Dickinson JA; Fisher S; Winget M
BMC Health Serv Res; 2016 Feb; 16():65. PubMed ID: 26892589
[TBL] [Abstract][Full Text] [Related]
34. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer screening effectiveness in Portugal central Region.
Bastos J; Rodrigues V; Paap E; Broeders M; Pina M; Cruz D; Carrito B; António Silva M
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S204-S207. PubMed ID: 28574867
[TBL] [Abstract][Full Text] [Related]
36. Interval cancer rates in the Irish national breast screening programme.
O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
[TBL] [Abstract][Full Text] [Related]
37. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing.
Pathmanathan N; Provan PJ; Mahajan H; Hall G; Byth K; Bilous AM; Balleine RL
Breast; 2012 Dec; 21(6):724-9. PubMed ID: 23099207
[TBL] [Abstract][Full Text] [Related]
39. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
Majid S; Rydén L; Manjer J
World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
